TY - JOUR
T1 - Characterization of humoral responses to soluble trimeric HIV gp140 from a clade A Ugandan field isolate
AU - Visciano, Maria Luisa
AU - Tagliamonte, Maria
AU - Stewart-Jones, Guillaume
AU - Heyndrickx, Leo
AU - Vanham, Guido
AU - Jansson, Marianne
AU - Fomsgaard, Anders
AU - Grevstad, Berit
AU - Ramaswamy, Meghna
AU - Buonaguro, Franco M.
AU - Tornesello, Maria Lina
AU - Biswas, Priscilla
AU - Scarlatti, Gabriella
AU - Buonaguro, Luigi
PY - 2013
Y1 - 2013
N2 - Trimeric soluble forms of HIV gp140 envelope glycoproteins represent one of the closest molecular structures compared to native spikes present on intact virus particles. Trimeric soluble gp140 have been generated by several groups and such molecules have been shown to induce antibodies with neutralizing activity against homologous and heterologous viruses. In the present study, we generated a recombinant trimeric soluble gp140, derived from a previously identified Ugandan A-clade HIV field isolate (gp140(94UG018)). Antibodies elicited in immunized rabbits show a broad binding pattern to HIV envelopes of different clades. An epitope mapping analysis reveals that, on average, the binding is mostly focused on the C1, C2, V3, V5 and C5 regions. Immune sera show neutralization activity to Tier 1 isolates of different clades, demonstrating cross clade neutralizing activity which needs to be further broadened by possible structural modifications of the clade A gp140(94UG018). Our results provide a rationale for the design and evaluation of immunogens and the clade A gp140(94UG018) shows promising characteristics for potential involvement in an effective HIV vaccine with broad activity.
AB - Trimeric soluble forms of HIV gp140 envelope glycoproteins represent one of the closest molecular structures compared to native spikes present on intact virus particles. Trimeric soluble gp140 have been generated by several groups and such molecules have been shown to induce antibodies with neutralizing activity against homologous and heterologous viruses. In the present study, we generated a recombinant trimeric soluble gp140, derived from a previously identified Ugandan A-clade HIV field isolate (gp140(94UG018)). Antibodies elicited in immunized rabbits show a broad binding pattern to HIV envelopes of different clades. An epitope mapping analysis reveals that, on average, the binding is mostly focused on the C1, C2, V3, V5 and C5 regions. Immune sera show neutralization activity to Tier 1 isolates of different clades, demonstrating cross clade neutralizing activity which needs to be further broadened by possible structural modifications of the clade A gp140(94UG018). Our results provide a rationale for the design and evaluation of immunogens and the clade A gp140(94UG018) shows promising characteristics for potential involvement in an effective HIV vaccine with broad activity.
U2 - 10.1186/1479-5876-11-165
DO - 10.1186/1479-5876-11-165
M3 - Article
C2 - 23835244
SN - 1479-5876
VL - 11
JO - Journal of Translational Medicine
JF - Journal of Translational Medicine
IS - 165
ER -